ENvue MedicalFEED -8.77%34 Market Cap is $3.19 Mil as of Jul. 05, 2026. GuruFocus rates FEED with a GF Score™ of 34/100 and a GF Value™ of $5.13 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 868 Medical Devices & Instruments companies, ENvue Medical ranks worse than 94.35% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). ENvue Medical's share price for the quarter that ended in Mar. 2026 was $2.38. ENvue Medical's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 3.70 Mil. Therefore, ENvue Medical's market cap for the quarter that ended in Mar. 2026 was $8.81 Mil.
ENvue Medical's quarterly market cap
declined
from Sep. 2025 ($5.70 Mil) to Dec. 2025 ($2.54 Mil) but then
increased
from Dec. 2025 ($2.54 Mil) to Mar. 2026 ($8.81 Mil).
ENvue Medical's annual market cap
increased
from Dec. 2023 ($2.40 Mil) to Dec. 2024 ($2.47 Mil) and
increased
from Dec. 2024 ($2.47 Mil) to Dec. 2025 ($2.54 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. ENvue Medical's Enterprise Value for Today is $2.17 Mil.
ENvue Medical (NAS:FEED) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
ENvue Medical Market Cap Related Terms
ENvue Medical Market Cap Historical Data
* Premium members only.
The historical data trend for ENvue Medical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, ENvue Medical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ENvue Medical Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ENvue Medical's Market Cap distribution charts can be found below:
* The bar in red indicates where ENvue Medical's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
ENvue Medical's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ENvue Medical (FEED) has a Market Cap of $3.19 Mil as of Jul. 05, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on ENvue Medical and its competitors. According to the industry distribution chart, ENvue Medical ranks #819 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 94.4%.
Is ENvue Medical's Market Cap too high?
ENvue Medical's current Market Cap is $3.19 Mil. The Medical Devices & Instruments industry median Market Cap is 122.08. ENvue Medical's value of $3.19 Mil is 97.4% below this industry median. Based on the distribution chart, ENvue Medical ranks #819 out of 868 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, ENvue Medical has a GF Score™ of 34/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ENvue Medical's Market Cap compare to BTCY and LUDG?
According to the Medical Devices & Instruments industry distribution chart, ENvue Medical ranks #819 out of 868 companies for Market Cap. This places ENvue Medical in the lower half of its industry. The industry median Market Cap is 122.08. ENvue Medical's value of $3.19 Mil is 97.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 122.08, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ENvue Medical's current Market Cap of $3.19 Mil is 97.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on ENvue Medical and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 122.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ENvue Medical's current Market Cap is $3.19 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ENvue Medical stock overvalued right now?
Based on GuruFocus' analysis, ENvue Medical (FEED) is currently considered Possible Value Trap. The stock's GF Value™ is $5.13, compared to a current price of $0.52 — trading 89.8% below its estimated fair value. The current Market Cap is $3.19 Mil and 97.4% below the Medical Devices & Instruments industry median of 122.08. ENvue Medical's overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For ENvue Medical (FEED), the current Market Cap is $3.19 Mil as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ENvue Medical (FEED) Overvalued in 2026?
Based on GuruFocus' analysis, ENvue Medical stock appears to be undervalued.
The current stock price of $0.52 is trading 89.8% below its estimated GF Value™ of $5.13.
GuruFocus considers ENvue Medical to be Possible Value Trap.
Key valuation signals for FEED:
Market Cap: $3.19 Mil
GF Value™: $5.13 vs. price of $0.52 (89.8% below fair value)
Industry Position: 97.4% below the Medical Devices & Instruments median (#819 of 868)
No single metric tells the full story. See the FEED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ENvue Medical Inc develops medical devices for enhanced navigation in clinical procedures. The company provides personalized navigation technology to assist clinicians in placing feeding tubes safely and efficiently. Its ENvue system uses smart feeding tubes with sensors, body mapping, and continuous visual guidance to confirm accurate positioning and reduce complications like lung misplacement. The company conducted the business through two primary operating segments: NanoVibronix and ENvue. The firm generates the majority of its revenue from NanoVibronix, which derives revenues from selling its products directly to patients as well as through distributor agreements. ENvue derives revenues from selling its Systems and Nasoenteral tubes.
34GF Score
Get the complete analysis for FEED
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FEED has been successfully added to your 
